par de Castro, Gilberto;Puglisi, Fabio;de Azambuja, Evandro
;El Saghir, Nagi S;Awada, Ahmad 
Référence Critical reviews in oncology/hematology, 59, 1, page (40-50)
Publication Publié, 2006-07


Référence Critical reviews in oncology/hematology, 59, 1, page (40-50)
Publication Publié, 2006-07
Article révisé par les pairs
Titre: |
|
Auteur: | de Castro, Gilberto; Puglisi, Fabio; de Azambuja, Evandro; El Saghir, Nagi S; Awada, Ahmad |
Informations sur la publication: | Critical reviews in oncology/hematology, 59, 1, page (40-50) |
Statut de publication: | Publié, 2006-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Angiogenesis |
Antiangiogenesis agents | |
Bevacizumab | |
Metronomic chemotherapy | |
Molecular-target therapy | |
Sorafenib | |
Vascular endothelial growth factor | |
MeSH keywords: | Angiogenesis Inhibitors -- therapeutic use |
Clinical Trials as Topic | |
Humans | |
Neoplasms -- blood supply | |
Neoplasms -- drug therapy | |
Neovascularization, Pathologic | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1040-8428 |
info:doi/10.1016/j.critrevonc.2006.02.007 | |
info:pii/S1040-8428(06)00043-6 | |
info:scp/33745141942 | |
info:pmid/16600618 |